NCT00819247 - The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer | Biotech Hunter

Enrollment

129

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

May 31, 2002

Study Completion Date

August 31, 2002

Conditions

Prostate Cancer

Interventions

DRUG

Degarelix

Given as a subcutaneous injection.

Trial Locations (16)

Ayr Hospital, Ayr

Bristol Royal Infirmary, Bristol

Southmead Hospital, Bristol

St. Richards Hospital, Chichester

Glan Clwyd Hospital, Denbighshire

Ninewells Hospital, Dundee

Southern General Hospital, Glasgow

Leicester General Hospital, Leicester

Chelsea and Westminster Hospital, London

Kings College Hospital, London

St. Bartholemews Hospital, London

Derriford Hospital, Plymouth

Lister Hospital, Stevenage

Stirling Royal Infirmary, Stirling

Morriston Hospital, Swansea

Pindersfields General Hospital, Wakefield